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Placebo to Prevent Atriai Fibrillation in Patianta
Undergoing Coronary Artery Bypaaa Graft
Surgery
J.D.Radle,S. Khurana,R.Marzan,J. Bassett,N.Tepe,D.Westveer,
J.R.Stewart,H.Frumin.William Beaumont Hospital, Royal Oak, Ml, USA
Post operative atnalfibrillation(AF)occursin20-40%of patientaundergoing
coronaryarterybypaasgraftsurgery(CABG).PoetoperativeA-fibmntributes
to delayedrecovery,increasedlengthof stay,and increasedhospitalcoat.
Weraportarandomizedcfable blindtrialmmparingoralamicdarone(AMIO)
toplaceboforthepreventionA-fibafterCABG.AllpatientsundergoingCABG
wereconsideredeligible.Exclusioncriteriaincluded:sicksinus syndrome,
brsdycsrdia (< 50 BPM), A-fib within the last 6 months, and concurrent
therapywith VaughanWilliamsClassI or Ill anti-arrhyfhmicdrug.Patients
weregivenAMlO2 gm(63pte)orplacekm(64)ptein divided doses 1-3 days
prior and 400 m~day after CABG for 7 days. AF occurred in 25.5% (l&63)
of patients receiving AMIO and 31.2Y0 (20/64) of patients receiving placebo
OR 0.75, 95% mnfidenca interval 0.34-1.64, p 0.46. Heart rate at onset of
AF wee 122.9 + 49.4 BPM in patients on AMlOand 147.2+ 47.8 BPMin
thoseon placebo(p 0.06).Durationof AF was9.7houns+ 8.8 in thoseon
AMlOand 15.9 + 28.7 hrs on placebo(pO.67).Postoperativelengthof
staywee5.4+ 3.6 in thosewithoutAFand9.7+ 11.2for thosewithoutAF
(p0.@4).Conclusions: Poet CABG AF significantlyprolongedhospitalstay.
Prophylacticamiodaronedidnotsignificantlyraducetheincidence,hearfrate
at onset,or durationof postCABGatrialfibrillationin thedosesemployed.
D998146 influence of Left Ventricular Function in AoRicStenoeia on Riak of Valve Replacement and Long
Term Survivai
G.Ringwald,R.MOnzer,H.C.Mehmel.Sfi%YischesMinikum Karlsmhe,
Germany
Severelymmpromissdleftventricularfunctionis associatedwithincreased
risk in cardiacsurgery.We mmpared two groupsof patientswith heatt
catheterizationbetween1987and 1992andwithseveresymptomaticaortic
sfenoeis.Group1 (n = 60) showedan EF s 40%;group2 (n = 50) waa
randomlyselectedfromthe sametimeperiodandhadan EFz 60%.Mean
followupwas4 yeare.Peakto peakpressuregradientwas71&21.4 mmHg
ingroup1and91.7+ 31.5mmHgingroup2. Onepatientingroup2 denied
surgery,one patient in group 1 with Hodgkin’s disease preoperatively died of
sepsis.
EF< 40% EF >60%
Cardiacmortalltyonwaiting 6 of 50 1 of 49 p= 0,1
listforheartsurgery (12%) (2%)
5.6°/Jmonth 0.37Y!month
Mean waitingtime
p= 0.003
62days 160days p <0.001
Operstivemotislity 6 of 43 (16%) 1 of46 (2”A) p = 0.01
Operative mortality in group 1 patients without significant coronaty artery
diaaaee (CAD) was 1 of 25 (4%); with significant CAD 7 of 18 (39%); p =
0.006. During follow up patient mortalify/year was 0.023 in group 1 and 0.02
in group 2. All surviving patients in group 1 and 86% of patient6 in group 2
felt better than prsoperatively. Mean NYHA claes improved from 3.1 to 1.7 in
group 1 and 2.6 to 1.6 in group 2.
Conclusion: Significant aortic stenosis with low EF is an emergency in-
dication for aortic valve replacement. Waiting times should be as short as
possible. Operative mortality in patients with low EF, severe aortic stenosis
and significant mronaty artery diaease is extraordinarily high. During the
first years of follow up quality of life and life expectancy are mmparable in
patients with normal and low EF.
m998147 Faotora Aaeociated With Poatoparative Length of
Stey After Coronary Artery Bypaea Graft Surgery
1981 Through 1995
C.D. Warner,W.S.Weintraub,J.M.Craver,E.L.Jones,J.P.Gott,
R.A.Guyton.Emory Univemi~, Atlanta, GA, USA
Postoperative length of stay (PLOS) following coronaty artary bypass graft
surgery (CABG) has decreased significantly in recent years. In an analysis
of 23,512 patients who had CABG from 1861 through 1995, mean PLOS
declined from 6.2 (s.d. 6.0) days in 1981 (median 7) to 8.74 (ad 6.7) days in
1995 (median 5) (p < 0.001). Categorizing patients by time periods, Group 1
1961 through 1S67,Group 21966 through 1992, and Group 31993 through
1995, illustrated the change in PLOS. Group 2 ahowsd an increase in PLOS;
significant dacreaae in PLOS did not occur until 1993-1995. in multivariate
analyais uaing the natural log of PLOS, 26Y0 of the variability in PLOS wee
accounted for by year of ‘CABG, age, sex, ejection fraction, CHF, diabetes,
emergent status, mortality,and these postoperative implications: Ml, sternal
wound infection, pneumonia, neurological eventa, ARDS, use of IABP, and
angina. With some variation in spacificvanables, the same factors acmuntad
for 16%of thevarfability in PLOS for Group 1, 27% for Group 2, and 3%’%for
Group 3.
Group1 n = 12088 Group2 n = 7296 Group 3 n = 4126 pvalue
PLOS (sol) 6.9 (6.1) 9.7 (26.4) 7.3 (7.4) <0,001
PLOS s 3 cf. 1.2% 1.96’% 5.7”/0 <0.001
PLOS s 4 d. 1.40/a 2.5% 30,0”/0 <0.001
1998-1481 Acute lachenliaAftt?r Coronary Artery Bypaea
Graft Surgery: The Role of Immediate
Catheterization and Angiopiaaty
G.S..Ledley, P.Campos, W.S. Hirsch, M.N. Kotier. A/bert Einsfeirr &fedica/
Centac Temp/eUniversity Schoo/ofMadicine, Philadelphia, PA, USA
Mymardial ischemia, occurring in the eerfy post operative period following
mronary artery bypass graft surgey, (CABG) is often treatad by reoperation,
or medical therapy. The purpose of this study was to determine the role of
cardiac catheterization and percutaneous transluminal corona~ angioplasty
(PTCA) for myocardial iechemia in the immediate post CABG period. 14
consecutive patients (mean age 64 years, 65% male) undergoing cardiac
catheterization after CABG surgery during the same hospitalization were
included. Clinical data, cardiovascular profile, surgical, diagnostic catheteri-
zation, and interventional procedural data were mllected and analyzed. The
patients underwent cardiac catheterization a mean of 3daysfollowing CABG,
with 6/14 occurring within the firet 24 hours. Indications for cardiac catheteri-
zation included; ischemic EKG changes- 100%, symptomatic angina-64%,
focal wall motion abnormalities on echocardiogrsphy - 78%, and hemody-
namic instability-21%. Findings at cardiac catheterization included 1 or more
new graft obstruction - 78%, native vessel obstruction 7%, and no identifiable
culprit (presumed spasm) – 14%. 5 patients undetwent successful PTCA. 2
of these were of obstructed grafts, and 3 were of the native vesaels supplied
by obstructed grafts. 3 patienta underwent an initial PTCA and then repeat
CABG, fora more mmplete revaecularization.
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Three patients were referred for repeat CABG, and 3 were treated medically.
Conclusion: 1) Cardiac catheterization and PTCA can be successfully per-
formed immediately following CABG, in patients with post operative myocar-
dial ischemia. A culprit vessel was identified in 65% of the patients. PTCA
was successful in achieving revaecularization in 35%, and as a bridge to
CABG in 21% of patients. Immediate cardiac catheterization and angioplasty
should be considered in patients developing acute myocardial ischemia after
CABG, as an alternative to rsoperation.
m998166 Long-Term Survival after Biological verauaMechanical Aortic Vaiva Rapiacement in 1156
Patiente
D.Petetseim, Y.-Y.Cen, S. Cheruvu, W,G. Wolfe, K. Landolfo, J.E. Lowe,
D.D. Glower. Duke University Durham, NC, USA
The effect of biological versus mechanical prostheses on long-term survival
remains mntrovemial. Therefore, outcomes were compared in 1156patients
undergoing aottic valve replacement (AVR) with Carpantier-Edwards stan-
dard (CE, N = 531) or St. Jude Medical (SJ, N = 625) prostheses..CE and &l
patients were well matched, except that CE patients had an earlier operation
date and older age (63 + 13 va 59 + 17 yre). Survival at 5/10/13 years was
similar in each group (69 + 2/46 & 2/35 + 3% for CEand 72 + 2/52 + 4/44
+5% for SJ, p = 0.2). Multivariable independent predictors of survival were
age, renal or lung disease, ejection fraction, mitral valve disease, coronary
diseaee, and previous median stemotomy. CE versus SJ prosthesis did not
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affectsurvivalfor all patientsor for any subgroup(p = 0.4). Independent
predictorsof reoperationwereyoungerage, CE prosthesis,and previous
medianstemotomy.In patientsover65 yearsold, choiceof prosthesisdid
not affectactual freedomfrom reoperation(99 + 1/97 * 1/95 + 2Y0 for
CE vs 98 + 1/98 + 1/98 + 1% for SJ, p = 0.4). Giventhat prosthesis
outlastmostpatientsundergoingAVR,choiceof prosthesishaslittleeffect
onsurvival.Prosthesiselectionshouldbeindividualizedbasedoniesuesof
antlcoagulationandreoperation.
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1999-1491 PrOgnOstiCVal”eOfDObutamineStm*S
EchocardiographyAfterHeatiTransplantation
C.H.Spes,H.Mud[a,S.D.Schnaack,V.Klauss,A.R.Tammen,J. Rieber,
K.-H.Henneke,P.Uberfuhr,K.Theisen,C.E.Angermann.Wveraityof
Munich, Munich, Germany
Dobutaminestressechocadiography(DSE)isa usefulmethodfordiagnmsis
of allogrsftvasculopathy.In this study,the prognosticvalueof DSE(5-
40 @@rein; assessmentof wall motionabnormalities(WMA)usinga 16
segmentmodel)wasanalyzedin S3patients(P,meanage50 A 10years)
late(?12, mean47 + 32 months)t$terhearttransplantation(HTX).Cardiac
events(myocerdiainfarction,needfor revascularization,heartfailure,re-
HTX, death) were registeredduringfollow-up.DSEwas also compared
with imonary angiographyand intravascularultrasound(IVUS,grades1-
6). Results: 167DSE,144angiogramsand 87 IVUSwereperformed(l-4
studiee/P).Withinan obsemationperiodof 1602patientmonths,15events
occurredin 10 P: revascularization,n = 9; re-HTX,n = 2; heartfailure,n
= 2; death,n = 2.14 of SOabnormalDSEand 1 of 87 normalDSEwere
followedby an event.AbnormalDSEstudiesfollowadbyan event(n = 14)
showadWMAin moresegments(7.3+ 4.2 vs.5.0 + 3.1, p < 0.05)anda
higherwallmotionscoreindex(1.52+ 0.30vs. 1.34+ 0.26,p c 0.05)than
abnormalDSEwithoutevent.Newlydevelop6dWMAoran increaseinWMA
scoreindexwere indicators of events in sertal studies.13 of 53 abnormal
angiogramsand 2 of 93 normalengiogramswerefollowedby an event.In
P with noor mild intimalhyparplasiaby IVUS(meanIVUSgrade< 3.0;26
of 87 studies),noeventoccurred.Conclusions: NoninvaeiveDSEmayadd
relevantprognosticinformationin P lateafter HTX.In P with normalDSE,
probabilityof clinicaleventsis low.The prognosticvalueof a normalDSE
studyis comparableto thatof a norinalangiogremafterHTX.
m999150 ComparativeVeiueof DobutemlneStrsasThallium-201SlnalePhotonEmieeionComDuted
Tomographyand”Echocardiographyinthe.
Dlagnoalaof CardiacAllograflArterjopathy
N.M.Lekkis,S.F.Nagueh,Z.-X.He,J.J.Mahmarian,M.S.Verani.Baylor
College of Medicine, Houston, TX, USA
Annualcoronatyangiographycontinuesto be the standardprccadureto
monitorforthedevelopmentandprogressionof coronatyallograftartertopa-
thyafterhearttransplantation.Exerciseperfusionimagingappearstoprovide
suboptimalresultsinthesepatients(pts).Thisstudywasdesignadtoassess
the comparativevalueof high-dose(maximum40 wg/kg/min)dobutamine
thallium-201single photonemissioncomputedtomography(SPECT)and
dobutaminestressechocardiography(DSE)to detectallograftarteriopethy.
Thirly-ninepts,2Sof whomweremales,witha meanposttransplantfollow-
UPtime of 48 + 6 (SD) months,were studied.All patientsexcept3 had
coronay angiography1 dayafterthe dobutaminestresstest. Medications
at thetimeof thetest includedcalciumantagonists(n= 19),ACEinhibitors
(n = 13), and beta blockers(n = 4). The meanbaselineand peak heart
rateswere86and139bpm(p < 0.0001),respectively.Only3 ptsdevelopad
ischemicST-segmentchangesand2 hadchestpain.Thecomparativesen-
aitivify,specificity,positiveand negativepredictivevaiueswereas follows:
TI.201SPECT:85%,78%,46%,96%;and OSE:57%,94%,67%,91%.In
conclusion,this studyis uniquefor 2 reasons:first, it is the first to assess
the comparativevalueof both dobutamineTI-201SPECTand DSEdone
concomitantlyin cenliactransplantrecipients:second,on the basisof our
results,dobutaminestresstestingis well toleratedand meritsconsidera-
tion as a screeningtest for allograftarteriopathylate after cardiactrans-
plantation.
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RelationshipBetweenDobutemineInduced
RegionalWallMotionAbnormalitiesandCoronarv
Flo-wReaarvain HeartTransplantPatienta -
WithoutAngiographicCoronaryDiaeeae
P.A.Jackson,K.O.Akosah,A.J.Minisi,H.M.Ibrahim,D.Kirchberg,
P.K.Mohanty.McGuire VAMedicel Center and Medicel College of Virginia,
Richmond, VA, USA
Regionalwall motionabnormalities(RWMA)demonstratedby dobutamine
stressechocardiography(DSE)is a sensitiveindicatorof mronary artery
disease(CAD)in the heatttransplant(HT)recipients.However,RWMAhas
beenshownto occurin patientswithangiographically“normal”corona~ar-
teries(ANCA).Wesoughtodetermineifabnormalresponsestodobutamine
inthissettingarerelatedtovasomotorabnormalities(VMA)incoronarycircu-
lationmanifestedbyabnormalcoronaryflow reserve(CFR).Methods: CFR
andwallmotionsmre index(WMSI)derivedfromDSEweremeasuredin 19
consecutivestableHTpatients.CFRwasmeasuredwiththedopplerFlo-Wire
andintrecoronaryadenosine.DSEwaspatformadwithin24 houraof CFR.
Resu/ts:CFRandRWMAresponseswerecorrelatedin32coronaryatteries
(19 patients)(Table).Fivepatients(7 coronaryarteries)wereexcludedfor
pooramusticwindow.Twenty-fivecoronatyarteriesexhibitednormalCFR
(> 2.0).Of these,21 (84%)correspondingall segmentsexhibitadRWMAS.
Fourcoronaryarterieswithcorrespondingwall segmentsthat exhibitadno
RWMAsalsohadnormalCFR.Therewaenorelationshipbetweenabnormal
DSEandCFRin 10of 14(71%)patients.
WMSI CFR (n = 14) p-Value
1,0 2.5 + 003 NS
>1.0 2.8 + 0,6 NS
Thesedatesuggestthat dobutaminestreesinducedRWMAwithoutan-
giographicCADhaspoorcorrelationwithCFRandthattheseinducedRWMA
mayberelatedto factorsotherthanVMAinthe HTpatients.
1999-152] Homocysteine,aRiskFactorfOrAtherosclerotlc
andThromboembolicVaecularDieeaee,ie Higher
in PatientswhoHaveUndergoneOtthotoDic
CardiacTransplantation -
A. Moustepha,A. Gupta,D.W.Jacobsen,R.Green,M.Goon_nastic,
E.M.Tuczu,J. Young,R.Hobbs,K.James,K.Robinson.The Cleveland
clinic Foundation, Cleveland, OH, USA
Background: Atherosclerosisis a majorcomplicationof hearttrensplante-
tion. A highplasmahomccysteine(HCY)concentrationis a riskfactorfor
atherosclerosisand maybe causedby lowfolate,vitaminB12or S6 levels
andrenalfailure.
Aims and Methods:To detectabnormalitiesof homocysteinemateboliem
in transplantpatients,total fastingplasmalevels were measuredin 106
recipients(82men,24women,age50+ 9 yrs)andwerecomparedwithage
andsexmatchedcontrols.Levelsof folate,vitaminsB12and B6aswellas
creatininewerealsodetermined.
Results: Homocysteinelevelswerehigherin recipients(16.5+ 8.6vs 11
+ 3.6&mol/L,p < 0.001)aswasserumcreatinine(1.65+ 1.6vs0.97+ 0.2
mg/dl,p c 0.001).A highhomocysteine(=-90 th percentilefor controle,14
&mol/L)wasseenin66 recipients(62Yo)comparedto 11controls(1OYO,p <
0.01).Homocysteinecorrelatednegativelywithfolate(r = -0.46, p < 0.01)
andvitaminB12(r= -0.23, p c 0.01)andpositivelywithcreatinine(r=0.19,
p= 0.08).
HCY B12 deficiency Folate deficiency 66 dsficiencv
pmol/L <125 pmoVL- <5.2 nmoVL <20 nrnoVL-
Controls 11.03 + 3.83 5 (4.80/n) 2 (1.9%)
Recipients
3 (2.9%)
16.52 + 8.64* 4 (4”/0) 20(20%)* 19 (20%)”
*p< 0.001
Concksions: A highplasmahomocysteineconcentrationisoftenseenin
transplantpatientsandis relatedto deficienciesof folateandvitaminB6as
wellasrenaldysfunction.Therelationshipbetweenhighhomocysteinelevels
and atheroscleroticomplicationsof cardiactransplantationrequirefurther
study.
1999-153/ CardiacAllograftReject10niaanh3dependent
RiskFactorforGraftCoronaryArteryDieease
LateAfterTransplantation
H.P.Brunner-LsRccca,W.Kiowski.Division of Cardiology, Univemify
Hospita/,Zurich, Swifzer/and
Thedevelopmentof graft coronaryarterydisease(g-CAD)hasbecomean
